baber/WOPTO huggingface dataset:
Patent EP-2195041-A2 (EP)
Title: Micro-membranes de barrière résorbables pour l'atténuation de tissu cicatriciel pendant la cicatrisation
Inventor: BLUECHER LUKAS
IPC: A61L31/04
Filed: 2008-08-27
Abstract: La présente invention concerne des micro-membranes de polymère de lactide résorbables. Les micro-membranes sont constituées de polymères résorbables de polylactide, qui sont conçus pour être absorbés dans le corps relativement lentement au cours du temps afin de réduire les effets secondaires négatifs potentiels. Les membranes sont formées de manière à avoir des épaisseurs très minces, par exemple, des épaisseurs comprises entre environ 0,010 mm et environ 0,300 mm. Les membranes peuvent être extrudées à partir de polymères de polylactide ayant une propriété de viscosité relativement élevée, peuvent être préformées avec des portions relativement épaisses, et peuvent être conservées dans des emballages stériles.
Patent EP-2090262-A2 (EP)
Inventor: MUELLER WOLFGANG
IPC: A61K6/847
Filed: 2009-02-04
Abstract: The device (10) has a frame (12) partially arranged in a housing, and a motor (14) supported by the frame. A mixing arm (16) is supported by the frame. Two bearings (30) are placed inside the housing, where each bearing is clamped between upper and lower elastic pretensioned damping elements (32, 34). The lower damping element (34) is supported on an upwardly directed abutment surface, and the upper damping element (32) is engaged by a downwardly directed abutment surface of the housing, where the upwardly directed abutment surface is formed on a stand foot.
Patent EP-2151444-A2 (EP)
Inventor: SAKANO YASUNORI
IPC: C07F7/21
Filed: 2009-07-28
Abstract: [SUBJECT] The purpose of the present invention is to provide a photo curable fluorine compound which has good compatibility with non-fluorine organic compounds, maintaining good properties as a fluorine compound.  [MEANS TO SOLVE THE PROBLEMS] A fluorine-containing acrylate or alpha-substituted, fluorine-containing acrylate represented by the following formula (1),   
wherein a is an integer of from 1 to 4, b is an integer of from 0 to 3, and c is an integer of from 1 to 4, provided that a + b + c is 3, 4, or 5; 
e is an integer of from 2 to 8; 
R 1  is a group represented by the following formula (2),  
 -(C 4 H 8 O) f (C 3 H 6 O) g (C 2 H 4 O) h (CH 2 O) i R 3 (2)  
wherein f, g, h, and i are, independently of each other, an integer of from 0 to 100, provided that a molecular weight of R 1  is in a range of 30 to 3000, 
these repeating units may be sequenced at random, and 
R 3  is a saturated or unsaturated hydrocarbon group having 1 to 10 carbon atoms; 
R 2  is, independently of each other, a hydrogen atom, a fluorine atom, a methyl group, or a trifluoromethyl group; 
Rf is a perfluoropolyether residue represented by the following formula (3),   
wherein j, k, l, and m are, independently of each other, an integer of from 0 to 50, provided that a molecular weight of Rf is in a range of 200 to 6000, 
X is a fluorine atom or a trifluoromethyl group, and 
these repeating units may be sequenced at random; 
Z is a divalent organic group; and 
d is 0 or 1.
Patent EP-2175544-A2 (EP)
Inventor: CRUISE NATHAN J
IPC: H02J7/04
Filed: 2009-10-07
Abstract: A battery charger is provided for implementing a charging method having a stepped output current. The battery charger includes: a power supply circuit that receives an AC input signal and outputs a DC output signal. The power supply circuit (30) includes a power supply controller (55) configured to receive a feedback signal indicative of current being output by the power supply circuit via an amplifier (57) and operates to control current output by the power supply circuit in accordance with the feedback signal. A charger controller (32) is interfaced with the power supply controller to implement a charging method having a stepped output current. The charger controller may set the output current level by adjusting gain of an operational amplifier having a negative feedback configuration with the feedback signal input to a non-inverting input terminal of the operational amplifier, where the charger controller sets the output current level by changing the resistance at an inverting input terminal of the operational amplifier.
Patent EP-2207215-A2 (EP)
Inventor: GRIS CHRISTIAN
IPC: H01L41/257
Filed: 2009-11-24
Abstract: A method of poling a ferroelectric sample (2a) suitable for use in a fuel injector (5) of an internal combustion engine, the method comprising providing a ferroelectric sample (2a) having a stack of ferroelectric layers (4), wherein adjacent layers (4) are separated by internal electrodes (6a, 6b), forming a first group (6a) and a second group (6b) of electrodes; applying a multiaxial pressure to the ferroelectric sample; reducing the bonding strength between each pair of adjacent ferroelectric layers and internal electrodes; and generating a first electric field between the first (6a) and second (6b) group of electrodes to pole each ferroelectric layer (4) in a first poling direction.
Patent EP-2098937-A2 (EP)
Inventor: PRIESTMAN GEOFFREY HUGH
IPC: F15C1/16
Filed: 2009-02-03
Abstract: Provision of flow control arrangements which can be switched from high flow restriction to low flow restriction or vice versa are desirable. It is known to use switched vortex valves comprising a vortex chamber having a diverter portion which jets a through flow into either radial presentation to an outlet or tangential presentation with differential flow restrictions. Typically deflection is through cross flows presented from control ports as determined by mechanically actuated and controlled valves. Sensors are required to determine pressure differentials in order to actuate these moving part valves. By providing association between the control ports and an outlet path along with appropriate configuration and sizing of the flow regulators switching states can be provided through the cross flows presented via the flow regulators between the high and low through flow restriction. The flow regulators generally comprise orifice restrictors, diffusers/venturi arrangements or vortex throttles.
Patent EP-2194671-A2 (EP)
Inventor: LONG MEN
IPC: H04L9/06
Filed: 2009-11-27
Abstract: Both end-to-end security and traffic visibility may be achieved by a system using a controller that derives a cryptographic key that is different for each client based on a derivation key and a client identifier that is conveyed in each data packet. The controller distributes the derivation key to information technology monitoring devices and a server to provide traffic visibility. For large key sizes, the key may be derived using a derivation formula as follows:      c   ⁢   l   ⁢   i   ⁢   e   ⁢   n   ⁢   t   _   k   ⁢   e   ⁢   y   _   M   ⁢   S   ⁢   B   =   A   ⁢   E   ⁢   S   ⁢   128     b   ⁢   a   ⁢   s   ⁢   e   _   k   ⁢   e   ⁢   y   _   1   ,   c   ⁢   l   ⁢   i   ⁢   e   ⁢   n   ⁢   t   _   ID     ,             c   ⁢   l   ⁢   i   ⁢   e   ⁢   n   ⁢   t   _   k   ⁢   e   ⁢   y   _   L   ⁢   S   ⁢   B   =   A   ⁢   E   ⁢   S   ⁢   128   ⁢     b   ⁢   a   ⁢   s   ⁢   e   _   k   ⁢   e   ⁢   y   _   2   ,   c   ⁢   l   ⁢   i   ⁢   e   ⁢   n   ⁢   t   _   I   ⁢   D   +   p   ⁢   ad     ,   a   ⁢   n   ⁢   d        client_key = client_key_MSB ∥ client_key_LSB, where (1) and (2) are executed in parallel. The client key and a client identifier may be used so that end-to-end security may be achieved.
Patent EP-2238029-A2 (EP)
Inventor: RIEDEL CHRISTIAN
IPC: B64D11/00
Filed: 2009-01-29
Abstract: System and method for the voltage supply of aircraft cabin modules (1). An electric supply voltage and an additive data signal are transmitted via a cable (3). The aircraft cabin modules (1) have a connection plug (2) for plugging onto the cable (3) and an isolating circuit (5), which isolates the transmitted supply voltage from the data signal.
Patent EP-2245017-A2 (EP)
Inventor: SRINIVAS VISWESWARA AKELLA SATYA SURYA
IPC: C07D401/04
Filed: 2009-01-30
Abstract: Described are novel heterocyclic compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof. These compounds are useful in the treatment of immunological diseases, inflammation, pain disorder, rheumatoid arthritis; osteoporosis; multiple myeloma; uveititis; acute and chronic myelogenous leukemia; atherosclerosis; cancer; cachexia; ischemic-induced cell damage; pancreatic beta cell destruction; osteoarthritis; rheumatoid spondylitis; gouty arthritis; inflammatory bowel disease; ARDS; psoriasis; Crohn's disease; allergic rhinitis; ulcerative colitis; anaphylaxis; contact dermatitis; muscle degeneration; asthma; COPD; bone resorption diseases; multiple sclerosis; sepsis; septic shock; toxic shock syndrome and fever. More particularly these compounds are useful as PDE4 inhibitors and are useful for treating PDE4 mediated diseases.
Patent EP-2249642-A2 (EP)
Inventor: NELSON ALAN FREDERICK
IPC: A01N25/04
Filed: 2009-02-12
Abstract: The present invention relates, inter alia, to a novel herbicide formulation comprising: (a) an aqueous phase; (b) an HPPD inhibitor in suspension in the aqueous phase; (c) an encapsulated chloroacetamide and/or an isoxazoline herbicide in suspension in the aqueous phase; (d) glyphosate and/or glufosinate or an agrochemically acceptable salt thereof, in solution in the aqueous phase. The invention further relates to a process for the preparation of an herbicide formulation of the invention and to a process for the control of unwanted vegetation.
Patent EP-2254804-A2 (EP)
Title: Fermeture ayant un bouchon destiné à minimaliser la formation de gouttes
Inventor: DANKS CHRISTOPHER A
IPC: B65D43/14
Filed: 2009-03-09
Abstract: L'invention concerne un système de fermeture de distribution (20) pour un récipient (22) ayant une ouverture (26) donnant sur l'intérieur du récipient. Le mode de réalisation préféré du système (20) comprend une fermeture (20) ayant un corps de fermeture (30) s'étendant depuis le récipient (22) au niveau de l'ouverture (26) du récipient et un bouchon (32) attaché de manière articulée au corps de fermeture (30). Le corps de fermeture (30) possède un bec verseur de distribution (60), et le bouchon (32) comprend un raccord creux (90) destiné à entrer dans le bec verseur (60). Un rebord de raccord (91) peut être mis en œuvre sur le raccord (90), s'étendant vers l'intérieur en direction de l'intérieur creux du raccord (90). Un rebord de bouchon (33) peut être mis en œuvre de manière supplémentaire ou comme variante sur la surface intérieure du bouchon (32), que l'on positionne dans l'intérieur creux du raccord (90).
Patent EP-2294061-A2 (EP)
Title: Antagonistes de la voie de la protéine hedgehog de phtalazine disubstituée
Inventor: HIPSKIND PHILIP ARTHUR
IPC: C07D401/04
Filed: 2009-04-01
Abstract: La présente invention concerne de nouveaux antagonistes de la voie de la protéine Hedgehog de phtalazine 1,4-disubstituée utiles dans le traitement du cancer.
Patent EP-2250503-A2 (EP)
Title: Procédés d'analyse de bactéries dans des échantillons au moyen de la capture de cellules entières et de l'analyse atp
Inventor: BOMMARITO G MARCO
IPC: G01N33/569
Filed: 2009-02-19
Abstract: L'invention concerne des procédés de capture de cellules bactériennes entières qui impliquent l'utilisation d'un ou de plusieurs anticorps présentant des spécificités antigéniques pour une ou plusieurs caractéristiques d'analytes distincts de la bactérie spécifique, puis l'analyse des cellules entières cible au moyen d'un dosage ATP direct ou indirect.
Patent EP-2283582-A2 (EP)
Inventor: SICHITIU MIHAIL L
IPC: H04B1/69
Filed: 2009-05-05
Abstract: The subject matter described herein includes methods, systems, and computer readable medium for scrambled communication of data to, from, or over a medium. According to one aspect, the subject matter described herein includes a method for communicating data in scrambled form to or over a medium. The method includes receiving analog or digital data to be transmitted to or over a medium. The method further includes modulating samples representing at least signal using the analog or digital data to produce data modulated signal samples. The method further includes scrambling the data modulated signal samples using a predetermined scrambling algorithm. The method further includes transmitting the scrambled data modulated signal samples to or over the medium. The method further includes descrambling samples received from the medium using the inverse of the predetermined scrambling algorithm to obtain the unscrambled modulated signal samples, which can then be demodulated to retrieve original data.
Patent EP-2350294-A2 (EP)
Inventor: SCHWARZ HANS-PETER
IPC: C12N15/85
Filed: 2009-10-27
Abstract: La présente invention concerne le développement d’un modèle animal pour soumettre à essai différents agents dans le traitement d’un trouble de la coagulation. Plus spécifiquement, l’invention concerne l’utilisation de multimères de poids moléculaire très élevé de facteur de von Willebrand (VWF) dans différentes souches de souris pour induire des symptômes de type purpura thrombopénique thrombotique (TTP) pour le développement d’un modèle chez la souris de TTP. L’invention concerne en outre des procédés pour générer de tels modèles de maladie chez l’animal et des procédés de criblage pour identifier des composés biologiquement actifs qui sont efficaces dans le traitement de TTP.
Patent EP-2291474-A2 (EP)
Title: Composition décorative et son procédé d'utilisation
Inventor: BURY RAFAEL
IPC: C08L35/06
Filed: 2009-06-01
Abstract: Une composition comprend une première charge en des quantités d'au moins 50 % sur la base du poids total de la composition et une seconde charge facultative. D'autres composants de la composition décorative comprennent une résine polymère, un solvant coalescent et de l'eau. Cette composition est sensiblement exempte de stuc, de ciment ou autres composants hydrauliques où l'action de prise agirait comme liant pour la composition. Elle est utile pour créer des textures sur la surface de murs intérieurs ou de plafonds.
Patent EP-2321415-A2 (EP)
Title: Complexe protéinique an3 et son utilisation dans la promotion de la croissance des végétaux
Inventor: DE JAEGER GEERT
IPC: A01H5/00
Filed: 2009-08-31
Abstract: Cette invention concerne un complexe protéinique à base d’An3. L’invention concerne par ailleurs l’utilisation du complexe pour favoriser la croissance des plantes, et une méthode de stimulation de la formation du complexe, en surexprimant au moins deux éléments du complexe.
Patent EP-2367622-A2 (EP)
Inventor: ASTEGGER MIRIAM FERNANDA
IPC: B01J19/12
Filed: 2009-09-09
Abstract: L'invention concerne un ensemble réacteur destiné à la postcondensation de polymères, l'utilisation de cet ensemble réacteur pour la postcondensation de nylon ou de polyéthylène téréphtalate ou pour le recyclage de polyéthylène téréphtalate, ainsi que des procédés de préparation de matériaux de recyclage de PET et de postcondensation de polymères tels que le polyamide ou le polyéthylène téréphtalate.
Patent EP-2321960-A2 (EP)
Title: Caméra grossissante multiposition portable
Inventor: RODRIQUEZ CARLOS M
IPC: H04N5/222
Filed: 2009-08-03
Abstract: L'invention concerne une caméra grossissante portable pouvant être positionnée sélectivement dans diverses configurations. Au moins quatre configurations de prise de vue distinctes sont disponibles : un mode de lecture dans lequel la caméra repose à plat sur l'objet de la prise de vue ; un mode d'écriture dans lequel la caméra repose selon un angle sur l'objet de la prise de vue ; un mode de transport à la main dans lequel l'utilisateur tient la caméra par rapport à un objet distant ; et un mode d'inspection dans lequel l'utilisateur tient l'objet de la prise de vue par rapport à la caméra. Ces configurations permettent à l'utilisateur de prendre efficacement des vues d'objets de différentes tailles et à des distances variables.
Patent EP-2370803-A2 (EP)
Title: Récupération moléculaire assistée par pression (pamr) de biomolécules, extraction d'antigène assistée par pression (paar) et histologie de tissu assistée par pression (path)
Inventor: O'LEARY TIMOTHY J
IPC: G01N35/00
Filed: 2009-12-03
Abstract: La présente invention porte sur un procédé permettant d’inverser une réticulation induite par fixation dans des échantillons de tissu qui ont été conservés pour un examen histologique. Le procédé met en jeu le placement du tissu fixé dans un liquide dans des conditions de température et de pression élevées qui sont suffisantes pour inverser la réticulation induite par fixation, restaurer l'antigénicité de protéines et permettre une analyse moléculaire et protéomique améliorée de l'échantillon de tissu conservé. L'invention porte également sur des procédés de traitement de tissus pour un examen histologique dans des conditions de pression élevée qui améliorent la perfusion de réactifs liquides dans le tissu et réduisent les temps de traitement globaux.
Patent EP-2204859-A2 (EP)
Inventor: OHNO AKIRA
IPC: H05B33/14
Filed: 2003-02-13
Abstract: The present invention relates to a light emitting device comprising: 
a first light emitter emitting light of from 350 to 415 nm and 
a second light emitter emitting visible light by exposure to the light from the first light emitter, wherein said second light emitter comprises a phosphor having a crystal phase having a chemical composition of the following formula [4]: 
 
         EU o M 8   p (PO 4 ) q (BO 3 ) 2-q Z r      [4] 
 
(wherein, M 8  represents a metal element which contains Ca and 80 mol% or greater of which is composed of at least one element selected from the group consisting of Ca and Mg; Z represents an anionic group other than PO 4   3-  and BO 3   3- ; o stands for a number satisfying 0.003≤o≤2.1, p stands for a number satisfying 2.7≤(o+p) ≤3.3, q stands for a number satisfying 1.2≤q≤2 and r stands for a number satisfying 0≤r≤0.1).
Patent EP-2233411-A2 (EP)
Inventor: REIST WALTER
IPC: B65G35/00
Filed: 2005-03-11
Abstract: Conveying device comprises at least one conveying body (10), and roller bodies (1, 1') with at least two rollers (2). The roller bodies are arranged between guide rails (6, 6') and the conveying body so that the rollers freely rotate on displacement of the conveying body. An independent claim is also included for a process for conveying objects. Preferred Features: A connecting body (4) for the roller bodies is made of an elastic material.
Patent EP-2284857-A2 (EP)
Inventor: DEPPING CHRISTIAN
IPC: H01H37/76
Filed: 2010-07-28
Abstract: The element (1) has a connecting element (6) in electrically contact with a terminal contact (5) and a pole of a varistor (3) via a thermally separating connection. The connection is separated when the temperature of the component exceeds a preset boundary temperature. A spring system exerts a force that causes the connecting element to move out of electrically contact with the terminal contact and the pole. The connecting element is connected to an insulating disconnecting element (10) so that the disconnecting element is moved between the terminal contact and the pole.
Patent EP-2263679-A2 (EP)
Inventor: JANSEN BURKHARD
IPC: A61K38/00
Filed: 2003-08-21
Abstract: RNAi sequences that are useful as therapeutics in the treatment of cancers of various types, including prostate cancer, sarcomas such as osteosarcoma, renal cell carcinoma, breast cancer, bladder cancer, lung cancer, colon cancer, ovarian cancer, anaplastic large cell lymphoma and melanoma; and Alzheimer's disease. These sequences target clusterin, IGFBP-5, IGFBP-2, both IGFBP-2 and -5 simultaneously, Mitf, and B-raf. The invention further provides for the use of these RNAi sequences in the treatment of cancers of various types, including prostate cancer, sarcomas such as osteosarcoma, renal cell carcinoma, breast cancer, bladder cancer, lung cancer, colon cancer, ovarian cancer, anaplastic large cell lymphoma and melanoma; and Alzheimer's disease, and a method of treating such conditions through the administration of the RNA molecules with RNAi activity to an individual, including a human individual in need of such treatment.
Patent EP-2275125-A2 (EP)
Inventor: MIZRACHI NEBENZAHL YAFFA
IPC: A61K39/00
Filed: 2003-04-01
Abstract: The present invention relates to a vaccine composition comprising as an active ingredient an effective amount of an isolated  S .  pneumoniae  cell division protein FtsZ (FtsZ, Accession No. NP_346105), optionally together with one or more pharmaceutically acceptable adjuvant(s).
Patent EP-2343047-A2 (EP)
Inventor: WEST JENNIFER L
IPC: A61K33/243
Filed: 2001-02-08
Abstract: This invention is generally in the field of improved methods for the localized delivery of heat and the localised imaging of biological materials. The delivery may be  in vitro  or  in vivo  and is useful for the localized treatment of cancer, inflammation or to other disorders involving overproliferation of tissue. The method is also useful for diagnostic imaging. The method involves localized induction of hyperthermia in a cell or tissue by delivering nanoparticles to said cell or tissue and exposing the nanoparticles to an excitation source under conditions wherein they emit heat.
Patent EP-2327451-A2 (EP)
Inventor: VARNER JUDITH A
IPC: A61K38/08
Filed: 1999-05-07
Abstract: The present invention provides methods for reducing or inhibiting angiogenesis in a tissue, by contacting α5β1 integrin in the tissue with an agent that interferes with specific binding of the α5β1 integrin to a ligand expressed in the tissue; and methods of identifying angiogenesis in a tissue, by contacting the tissue with an agent that specifically binds α5β1 integrin, and detecting specific binding of the agent to α5β1 integrin associated with a blood vessel in the tissue. Also provided are methods of diagnosing a pathological condition characterized by angiogenesis in a tissue in an individual. The invention further provides methods of reducing or inhibiting angiogenesis in a tissue in an individual, by administering to the individual an agent that interferes with the specific binding of α5β1 integrin to a ligand expressed in the tissue; and methods of reducing the severity of a pathological condition associated with angiogenesis in an individual, by administering to the individual an agent that interferes with specific binding of α5β1 integrin to a ligand in a tissue associated with the pathological condition. The invention also provides methods of identifying an agent that reduces or inhibits angiogenesis associated with α5β1 integrin expression in a tissue by contacting a tissue exhibiting angiogenesis associated with α5β1 integrin expression with an agent, and detecting a reduction or inhibition of angiogenesis in the tissue.
Patent EP-2314777-A2 (EP)
Inventor: SCHLADITZ BERND
IPC: E03F5/04
Filed: 2010-10-13
Abstract: The storm drain (1) has a lower outlet chamber separated from an upper inlet chamber (5) by an inlet chamber separating base (9), and a float for closing an outlet pipeline in the outlet chamber. The outlet chamber is divided into sub chambers e.g. valve chamber (7), slow down chamber (10) and sedimentation chambers (11, 12). The sedimentation chambers are separated by a separating wall that has a filter cage filled with charcoal, filter granulates or substrates and/or bioactivated carrier materials, where one of the sedimentation chambers is filled with the bioactivated carrier materials.